Interactive Transcript
0:00
Here, we have a 60 year old female with a history of stage
0:03
4 lung adenocarcinoma with history of
0:06
plural metastases now representing for her follow up to
0:09
her oncology appointment.
0:11
The patient actually has been tolerating chemotherapy but reports
0:14
increasing dyspnea and left upper quadrant
0:17
pain.
0:18
She's referred for CT scan of the chest after.
0:21
Interval chemotherapy has been administered.
0:25
So what do we see?
0:33
Interestingly in the reading room the CT
0:36
scan is unable to identify any discrete nodules.
0:39
Marvelous interval improvement
0:42
post chemotherapy no evidence of new
0:45
or residual pulmonary disease. So for
0:48
full rule out of the seminated disease. The patient
0:51
is actually scheduled for further Imaging with a PET scan.
0:55
So what do we see?
1:03
If you were able to identify.
1:06
This little guy.
1:07
Spot on so this is a new Tracer radio
1:10
Tracer uptake Focus that's adjacent
1:13
to the right bronchus into medius with potential
1:16
lymph node metastasis.
1:19
There's also intense tracer activity in the
1:22
anus and the rectum.
1:24
Which may represent recurrence of rectal metastasis?
1:27
And then there's a single small enhancing peritoneal nodule.
1:31
It's too small for complete characterization but concerning for
1:34
earlier recurrence of the peritoneal metastasis.
1:37
So we have uptake in the right bronchus intermedius.
1:41
Lymph node. We see radio Trace optic
1:44
in the anus and the rectum and then we see a little enhancing pattern
1:47
nodule which is what we're seeing right here.
1:51
So the patient scheduled for CT guide of
1:54
biopsy of the peritoneal because that steamed to speed the most
1:57
amenable site for percutaneous tissue
2:00
sampling by the IR Department.
2:03
So the time of biopsy Scout CT successfully
2:06
visualizes the patient's peritoneal nodule on the
2:09
right side.
2:10
So here we see this little nodule.
2:13
adjacent to the anterior abdominal
2:16
wall
2:18
and that is targeted for biopsy.
2:21
So what we see here is a series of Acquisitions obtained
2:25
during CT fluoroscopy as
2:28
the needle is advanced.
2:30
So the corn needle biopsy of the patient's peritoneal is
2:33
actually completed without complication.
2:36
Samples are starting formalin and sent for pathological analysis.
2:40
So what is the path report real?
2:43
It demonstrates. Actually, I have no carcinoma a few
2:46
days later and it's actually consistent with recurrent spread
2:49
of the patient's primary lung cancer to the
2:52
peritoneum very unfortunate.
2:54
So in conclusion, the patient's biopsy samples
2:57
were used for further molecular testing Foundation medicine
3:00
testing in this particular case to determine the patient's
3:03
eligibility for ongoing clinical trials. The patient
3:06
was ordered for an additional brain MRI to
3:09
rule out intracranial metastasis.
3:13
The patient continues to follow up with her oncology team and she
3:16
continues to be at the time of preparation of
3:19
this material on chemotherapy.